Prevalance of HbsAg, anti-HBs, anti-HCV and HIV in different patient groups

Objective & Hypothesis:In this study, the determination of HBsAg, anti-HBs, anti-HCV and anti-HIV positivities have been rised up by ELISA test on 4127 patients, 1843 of whom were females.

📊

Key Findings & Data:As a result, the positivity rates of HBsAg, anti-HBs and anti-HCV were determined %6.08 %31.7 %2.01 respectively while anti-HIV positivity was not observed in any case.

💡

Conclusion & Impact:The prevalances of HbsAg and anti-HCV were higher in male patients than female.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

In this study, the determination of HBsAg, anti-HBs, anti-HCV and anti-HIV positivities have been rised up by ELISA test on 4127 patients, 1843 of whom were females. As a result, the positivity rates of HBsAg, anti-HBs and anti-HCV were determined %6.08 %31.7 %2.01 respectively while anti-HIV positivity was not observed in any case. The prevalances of HbsAg and anti-HCV were higher in male patients than female.

Özet

Bu çalışmada, 1843'ü bayan olan 4127 hastada HBsAg, anti-HBs, anti-HCV ve anti-HIV pozitifliği tayini ELISA testi ile yapılmıştır. Sonuç olarak HBsAg, anti-HBs ve anti-HCV pozitiflik oranları sırasıyla %6.08 %31.7 ve %2.01 olarak belirlenirken, hiçbir hastada anti-HIV pozitifliği gözlenemeıniştir. HBsAg, %35.9 anti-HBs ve %1.4 anti-HCV saptanırken, 2284 erkekte ise %7.1 HBsAg ve anti-HCV prevalanslarının erkek hastalarda, bayanlara göre daha yüksek olduğu görülmüştür.

🔖

Cite This Article

GÜMÜŞOVA, O. S., ERDEM, G., OLDACAY, M. (2022). Prevalance of HbsAg, anti-HBs, anti-HCV and HIV in different patient groups. Klinik Laboratuvar Araştırma Derg., Cilt: 6 - Sayı: 2, 54–56. https://ajindex.com/articles/573707